仙琚制药(002332.SZ)收到醋酸地塞米松片一致性评价受理通知书

智通财经07-05

智通财经APP讯，仙琚制药(002332.SZ)发布公告，公司于近日收到国家药品监督管理局下发的醋酸地塞米松片一致性评价受理通知书。公司醋酸地塞米松片已批准上市的规格为0.75mg，批准文号为;国药准字H33020822，目前产品执行标准为《中国药典》2020年版二部。公告称，醋酸地塞米松片被国家药品监督管理局受理，标志着该品种一致性评价工作进入了审评阶段，公司将积极推进后续相关工作，如顺利通过...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2449244256?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-07-05 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2449244256","market":"hk","top_or_hot":-1,"title":"仙琚制药(002332.SZ)收到醋酸地塞米松片一致性评价受理通知书","media":"智通财经","content":"<div>\n<p>智通财经APP讯，仙琚制药(002332.SZ)发布公告，公司于近日收到国家药品监督管理局下发的醋酸地塞米松片一致性评价受理通知书。公司醋酸地塞米松片已批准上市的规格为0.75mg，批准文号为;国药准字H33020822，目前产品执行标准为《中国药典》2020年版二部。公告称，醋酸地塞米松片被国家药品监督管理局受理，标志着该品种一致性评价工作进入了审评阶段，公司将积极推进后续相关工作，如顺利通过...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1146149.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>仙琚制药(002332.SZ)收到醋酸地塞米松片一致性评价受理通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n仙琚制药(002332.SZ)收到醋酸地塞米松片一致性评价受理通知书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-05 17:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1146149.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，仙琚制药(002332.SZ)发布公告，公司于近日收到国家药品监督管理局下发的醋酸地塞米松片一致性评价受理通知书。公司醋酸地塞米松片已批准上市的规格为0.75mg，批准文号为;国药准字H33020822，目前产品执行标准为《中国药典》2020年版二部。公告称，醋酸地塞米松片被国家药品监督管理局受理，标志着该品种一致性评价工作进入了审评阶段，公司将积极推进后续相关工作，如顺利通过...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1146149.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0239","symbol_name":"医药制造","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1146149.html","article_id":"2449244256","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2449244256","pubTimestamp":1720170207,"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，仙琚制药(002332.SZ)发布公告，公司于近日收到国家药品监督管理局下发的醋酸地塞米松片一致性评价受理通知书。公司醋酸地塞米松片已批准上市的规格为0.75mg，批准文号为;国药准字H33020822，目前产品执行标准为《中国药典》2020年版二部。公告称，醋酸地塞米松片被国家药品监督管理局受理，标志着该品种一致性评价工作进入了审评阶段，公司将积极推进后续相关工作，如顺利通过一致性评价将增加其市场竞争力。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0239":"医药制造","BK0028":"国家队","SG9999014674.SGD":"Nikko AM All China Equity A SGD","002332":"仙琚制药"},"translate_title":"Xianju Pharmaceutical (002332. SZ) received the acceptance notice of consistency evaluation of dexamethasone acetate tablets","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002332":1},"content_text":"智通财经APP讯，仙琚制药(002332.SZ)发布公告，公司于近日收到国家药品监督管理局下发的醋酸地塞米松片一致性评价受理通知书。公司醋酸地塞米松片已批准上市的规格为0.75mg，批准文号为;国药准字H33020822，目前产品执行标准为《中国药典》2020年版二部。公告称，醋酸地塞米松片被国家药品监督管理局受理，标志着该品种一致性评价工作进入了审评阶段，公司将积极推进后续相关工作，如顺利通过一致性评价将增加其市场竞争力。","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2449244256"}